MEDROXYPROGESTERONE ACETATE

MEDROXYPROGESTERONE ACETATE was reported 0 times

MEDROXYPROGESTERONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OLFACTORY GROOVE MENINGIOMA 22 0.9565
1 INTRAOSSEOUS MENINGIOMA 15 0.8333
2 MENINGIOMA 12300 0.7869
3 PREGNANCY WITH INJECTABLE CONTRACEPTIVE 157 0.7371
4 PROGESTERONE RECEPTOR ASSAY POSITIVE 673 0.7206
5 MENINGIOMA BENIGN 637 0.6857
6 OESTROGEN RECEPTOR ASSAY POSITIVE 773 0.6817
7 INTRACRANIAL MENINGIOMA MALIGNANT 53 0.5955
8 CONTRALATERAL BREAST CANCER 102 0.4951
9 MALIGNANT BREAST LUMP REMOVAL 49 0.3657
10 BREAST CANCER FEMALE 9771 0.3654
11 BIOPSY BREAST ABNORMAL 29 0.3053
12 BREAST MICROCALCIFICATION 26 0.2167
13 BREAST CANCER METASTATIC 1384 0.1287
14 BREAST OPERATION 105 0.1284
15 BREAST LUMP REMOVAL 28 0.1223
16 PERSISTENT GENITAL AROUSAL DISORDER 23 0.0991
17 FIBROCYSTIC BREAST DISEASE 67 0.0908
18 BREAST CANCER 8169 0.0876
19 OVARIAN CANCER METASTATIC 71 0.0835
20 BREAST RECONSTRUCTION 30 0.0798
21 BREAST HYPERPLASIA 27 0.0767
22 ANOVULATORY CYCLE 15 0.0725
23 MAMMOGRAM ABNORMAL 47 0.0701
24 MASTECTOMY 116 0.0663
25 ENDOMETRIAL HYPERTROPHY 26 0.0653
26 BIOPSY BREAST 20 0.0641
27 UNINTENDED PREGNANCY 648 0.0620
28 INFERTILITY FEMALE 89 0.0572
29 OVARIAN CANCER 504 0.0546
30 CLEAR CELL RENAL CELL CARCINOMA 36 0.0517
31 ENDOMETRIAL DISORDER 21 0.0508
32 BREAST CALCIFICATIONS 40 0.0501
33 FALLOPIAN TUBE DISORDER 14 0.0475
34 INFERTILITY 70 0.0465
35 ENDOMETRIAL HYPERPLASIA 32 0.0395
36 PREGNANCY TEST POSITIVE 15 0.0382
37 BREAST CANCER RECURRENT 120 0.0380
38 LYMPHADENECTOMY 36 0.0369
39 ENDOMETRIAL CANCER 81 0.0368
40 CERVICITIS 16 0.0359
41 INJECTION SITE ABSCESS 85 0.0341
42 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 23 0.0338
43 AMENORRHOEA 557 0.0317
44 BLOOD OESTROGEN DECREASED 22 0.0313
45 SUPPRESSED LACTATION 23 0.0306
46 INVASIVE LOBULAR BREAST CARCINOMA 14 0.0273
47 BREAST CYST 47 0.0265
48 PREMENSTRUAL SYNDROME 36 0.0262
49 UTERINE DILATION AND CURETTAGE 23 0.0254
50 METRORRHAGIA 431 0.0252
51 POLYCYSTIC OVARIES 39 0.0251
52 INVASIVE DUCTAL BREAST CARCINOMA 67 0.0246
53 MENORRHAGIA 484 0.0246
54 UTERINE POLYP 44 0.0245
55 UTERINE HAEMORRHAGE 103 0.0242
56 SMEAR CERVIX ABNORMAL 34 0.0239
57 PREMATURE MENOPAUSE 22 0.0238
58 ADENOMYOSIS 14 0.0237
59 BENIGN BREAST NEOPLASM 24 0.0236
60 MENOMETRORRHAGIA 45 0.0236
61 ATROPHIC VULVOVAGINITIS 17 0.0233
62 RADIOTHERAPY 41 0.0214
63 OSTEOPENIA 309 0.0203
64 POSTMENOPAUSAL HAEMORRHAGE 51 0.0195
65 UTERINE DISORDER 45 0.0193
66 DYSFUNCTIONAL UTERINE BLEEDING 23 0.0189
67 GALLBLADDER CANCER 27 0.0184
68 INJECTION SITE ATROPHY 30 0.0182
69 DRUG EXPOSURE BEFORE PREGNANCY 18 0.0178
70 RENAL MASS 36 0.0175
71 HORMONE LEVEL ABNORMAL 84 0.0172
72 BREAST MASS 114 0.0170
73 BREAST DISORDER 34 0.0167
74 CERVICAL DYSPLASIA 36 0.0165
75 UTERINE LEIOMYOMA 119 0.0163
76 ABORTION MISSED 20 0.0157
77 DISTURBANCE IN SEXUAL AROUSAL 14 0.0152
78 VULVOVAGINAL DRYNESS 48 0.0148
79 OSTEOPOROTIC FRACTURE 28 0.0146
80 DYSPAREUNIA 66 0.0144
81 VAGINAL ODOUR 18 0.0143
82 HIRSUTISM 19 0.0143
83 BREAST DISCHARGE 25 0.0143
84 BREAST NEOPLASM 14 0.0136
85 PELVIC INFLAMMATORY DISEASE 20 0.0134
86 RADIATION SKIN INJURY 15 0.0129
87 SKIN STRIAE 19 0.0128
88 BREAST TENDERNESS 92 0.0122
89 MENSTRUAL DISORDER 101 0.0122
90 COLONIC POLYP 20 0.0121
91 BLOOD UREA DECREASED 15 0.0121
92 METASTASES TO LYMPH NODES 81 0.0120
93 OSTEOPOROSIS 492 0.0119
94 UTERINE PERFORATION 101 0.0119
95 OLIGOMENORRHOEA 26 0.0119
96 OVARIAN CYST 119 0.0119
97 SEBORRHOEIC KERATOSIS 17 0.0117
98 ENDOMETRIOSIS 54 0.0113
99 DEVICE OCCLUSION 159 0.0113
100 MENOPAUSE 29 0.0112
101 MENOPAUSAL SYMPTOMS 26 0.0112
102 DYSMENORRHOEA 148 0.0112
103 SYRINGE ISSUE 195 0.0111
104 ECTOPIC PREGNANCY 34 0.0110
105 JOINT INSTABILITY 15 0.0107
106 INCORRECT DOSE ADMINISTERED BY DEVICE 281 0.0107
107 LYMPHOEDEMA 72 0.0104
108 BENIGN INTRACRANIAL HYPERTENSION 13 0.0104
109 ILLUSION 17 0.0103
110 FINE MOTOR SKILL DYSFUNCTION 29 0.0100
111 DEVICE CONNECTION ISSUE 21 0.0099
112 MITRAL VALVE PROLAPSE 16 0.0096
113 COMPLEX REGIONAL PAIN SYNDROME 14 0.0095
114 VAGINAL HAEMORRHAGE 411 0.0095
115 BREAST SWELLING 25 0.0093
116 UTERINE SPASM 17 0.0093
117 HAEMORRHAGE IN PREGNANCY 13 0.0091
118 BREAST PAIN 94 0.0088
119 SPINAL OSTEOARTHRITIS 77 0.0088
120 PELVIC PAIN 159 0.0087
121 SERUM FERRITIN DECREASED 15 0.0087
122 HEAVY MENSTRUAL BLEEDING 78 0.0087
123 NEEDLE ISSUE 244 0.0084
124 COITAL BLEEDING 13 0.0083
125 LOSS OF LIBIDO 75 0.0083
126 CHOLECYSTITIS CHRONIC 55 0.0082
127 PRE-EXISTING CONDITION IMPROVED 51 0.0082
128 LIQUID PRODUCT PHYSICAL ISSUE 58 0.0079
129 MEDICAL DEVICE PAIN 17 0.0079
130 BREAST ENLARGEMENT 26 0.0079
131 LIVEDO RETICULARIS 16 0.0077
132 INJECTION SITE INFLAMMATION 38 0.0076
133 INJECTION SITE INFECTION 25 0.0076
134 PRODUCT ADMINISTRATION ERROR 152 0.0075
135 DEVICE LEAKAGE 326 0.0075
136 TUNNEL VISION 14 0.0075
137 WHITE BLOOD CELLS URINE POSITIVE 14 0.0074
138 SCOLIOSIS 46 0.0074
139 MENSTRUATION IRREGULAR 195 0.0073
140 LACTOSE INTOLERANCE 18 0.0070
141 INTERMENSTRUAL BLEEDING 39 0.0070
142 THROMBOPHLEBITIS SUPERFICIAL 21 0.0069
143 COMA SCALE ABNORMAL 20 0.0069
144 MEDICAL DEVICE DISCOMFORT 21 0.0069
145 LUMBAR SPINAL STENOSIS 20 0.0068
146 HYSTERECTOMY 59 0.0068
147 GALLBLADDER INJURY 13 0.0067
148 STRESS FRACTURE 36 0.0067
149 ABNORMAL UTERINE BLEEDING 17 0.0066
150 BRAIN NEOPLASM 60 0.0065
151 DEFORMITY 61 0.0065
152 ABORTION 19 0.0065
153 DRUG EXPOSURE DURING PREGNANCY 221 0.0065
154 BREAST CANCER STAGE III 42 0.0065
155 DEEP VEIN THROMBOSIS 421 0.0065
156 VAGINAL INFECTION 30 0.0064
157 BREAST CANCER STAGE II 53 0.0064
158 SCAR 109 0.0064
159 TEMPOROMANDIBULAR JOINT SYNDROME 17 0.0064
160 POLYMENORRHOEA 22 0.0063
161 BLOOD PRESSURE DIASTOLIC ABNORMAL 16 0.0063
162 MOOD SWINGS 200 0.0063
163 DEVICE MECHANICAL ISSUE 86 0.0063
164 ABORTION SPONTANEOUS 247 0.0062
165 CERVIX CARCINOMA 24 0.0061
166 PRODUCT USE COMPLAINT 95 0.0060
167 VAGINAL DISCHARGE 61 0.0060
168 CEREBROVASCULAR DISORDER 18 0.0060
169 BLOOD PRESSURE DIASTOLIC DECREASED 44 0.0060
170 GOITRE 24 0.0059
171 BLOOD PRESSURE DIASTOLIC INCREASED 27 0.0058
172 INTERVERTEBRAL DISC DEGENERATION 52 0.0056
173 RHINITIS ALLERGIC 25 0.0056
174 DIVERTICULUM 39 0.0055
175 MUSCLE FATIGUE 23 0.0054
176 EMBOLISM VENOUS 16 0.0053
177 CARTILAGE INJURY 13 0.0053
178 UTERINE CANCER 42 0.0052
179 VARICOSE VEIN 27 0.0052
180 POOR QUALITY DEVICE USED 52 0.0052
181 GENITAL HAEMORRHAGE 66 0.0051
182 PULMONARY EMBOLISM 486 0.0051
183 GALACTORRHOEA 32 0.0050
184 DIFFICULTY IN WALKING 17 0.0049
185 DEPRESSION SUICIDAL 17 0.0049
186 OTITIS MEDIA 16 0.0048
187 PEPTIC ULCER 16 0.0048
188 GALLBLADDER DISORDER 86 0.0048
189 RED CELL DISTRIBUTION WIDTH INCREASED 20 0.0048
190 MATERNAL EXPOSURE TIMING UNSPECIFIED 18 0.0048
191 ANXIETY DISORDER 16 0.0048
192 BIPOLAR DISORDER 52 0.0048
193 APPENDICECTOMY 17 0.0048
194 VITAMIN B12 DEFICIENCY 19 0.0047
195 ACNE CYSTIC 14 0.0046
196 DEVICE DEFECTIVE 80 0.0046
197 LOW TURNOVER OSTEOPATHY 18 0.0045
198 HIGH DENSITY LIPOPROTEIN DECREASED 15 0.0045
199 HAIR GROWTH ABNORMAL 31 0.0045
200 BONE DENSITY DECREASED 139 0.0044
201 DECREASED INTEREST 26 0.0044
202 MONOCYTE COUNT INCREASED 16 0.0044
203 SCLERODERMA 16 0.0044
204 MAJOR DEPRESSION 32 0.0044
205 ONYCHOMYCOSIS 19 0.0043
206 BONE MARROW DISORDER 13 0.0043
207 INJURY 301 0.0043
208 PREGNANCY 85 0.0042
209 GLUCOSE TOLERANCE IMPAIRED 25 0.0042
210 VULVOVAGINAL PAIN 20 0.0041
211 FOOT FRACTURE 78 0.0041
212 SKIN LACERATION 44 0.0040
213 HYPERACUSIS 15 0.0040
214 HYPERLIPIDAEMIA 48 0.0040
215 DEPRESSION 909 0.0040
216 PSYCHIATRIC SYMPTOM 29 0.0039
217 THROMBOSIS 316 0.0039
218 MOOD ALTERED 107 0.0039
219 HYPERKERATOSIS 21 0.0038
220 ABDOMINAL PAIN LOWER 96 0.0038
221 POST-TRAUMATIC STRESS DISORDER 25 0.0037
222 WEIGHT FLUCTUATION 39 0.0037
223 EAR PRURITUS 13 0.0037
224 DRUG DOSE OMISSION BY DEVICE 290 0.0037
225 HOMICIDAL IDEATION 15 0.0037
226 CARDIAC MURMUR 32 0.0037
227 WEIGHT INCREASED 828 0.0037
228 VISUAL DISTURBANCE 21 0.0037
229 SKIN ATROPHY 21 0.0036
230 LOW DENSITY LIPOPROTEIN INCREASED 28 0.0036
231 BLOOD PROLACTIN INCREASED 17 0.0036
232 NERVE INJURY 40 0.0036
233 MIGRAINE 343 0.0036
234 SUSPECTED OFF LABEL USE 16 0.0035
235 MATERNAL DRUGS AFFECTING FOETUS 27 0.0035
236 NEUTROPHIL COUNT INCREASED 36 0.0035
237 ENDOCARDITIS 18 0.0035
238 MUSCLE STRAIN 30 0.0035
239 BLOOD IRON DECREASED 41 0.0035
240 THYROID DISORDER 53 0.0034
241 CHEMOTHERAPY 13 0.0034
242 DENTAL CARIES 38 0.0034
243 MELANOCYTIC NAEVUS 15 0.0034
244 HYPERCHOLESTEROLAEMIA 33 0.0034
245 LIGAMENT RUPTURE 15 0.0034
246 DEVICE PHYSICAL PROPERTY ISSUE 26 0.0034
247 PANIC ATTACK 123 0.0034
248 IRRITABLE BOWEL SYNDROME 72 0.0034
249 MITRAL VALVE INCOMPETENCE 38 0.0034
250 HOT FLUSH 253 0.0034
251 BONE DISORDER 61 0.0033
252 EPIGASTRIC DISCOMFORT 13 0.0033
253 BLOOD CHOLESTEROL INCREASED 155 0.0033
254 WEIGHT LOSS POOR 17 0.0033
255 TIC 18 0.0033
256 HAEMOGLOBIN INCREASED 15 0.0033
257 TRICUSPID VALVE INCOMPETENCE 26 0.0033
258 TONSILLITIS 17 0.0033
259 MENISCUS INJURY 20 0.0032
260 DIABETIC NEUROPATHY 16 0.0032
261 GASTROENTERITIS 47 0.0032
262 EMOTIONAL DISORDER 99 0.0032
263 INFUSION SITE ERYTHEMA 27 0.0032
264 PHARYNGOLARYNGEAL PAIN 17 0.0032
265 VITAMIN D DEFICIENCY 31 0.0032
266 EXOSTOSIS 29 0.0032
267 TOOTHACHE 57 0.0031
268 RENAL CYST 25 0.0031
269 WRONG DRUG ADMINISTERED 28 0.0031
270 OSTEOARTHRITIS 133 0.0031
271 MENSTRUATION DELAYED 34 0.0031
272 SUBCUTANEOUS ABSCESS 15 0.0031
273 BREAST CANCER STAGE I 29 0.0031
274 MEDICAL DEVICE COMPLICATION 23 0.0031
275 PAPILLOEDEMA 14 0.0031
276 POOR QUALITY DRUG ADMINISTERED 20 0.0031
277 LARYNGEAL OEDEMA 19 0.0031
278 CRYING 112 0.0031
279 TENDERNESS 32 0.0031
280 CHOLELITHIASIS 100 0.0030
281 FIBROMYALGIA 74 0.0030
282 CHOLECYSTITIS ACUTE 17 0.0030
283 ANGER 101 0.0030
284 HEREDITARY ANGIOEDEMA 32 0.0030
285 CHOLECYSTECTOMY 34 0.0030
286 INFUSION SITE PAIN 38 0.0029
287 MOUTH SWELLING 17 0.0029
288 GINGIVAL SWELLING 13 0.0029
289 HAEMORRHOIDS 57 0.0029
290 PERIPHERAL VASCULAR DISORDER 15 0.0029
291 DEAFNESS UNILATERAL 16 0.0029
292 PREGNANCY WITH CONTRACEPTIVE DEVICE 26 0.0029
293 IMPAIRED WORK ABILITY 62 0.0029
294 PRODUCT PHYSICAL CONSISTENCY ISSUE 16 0.0029
295 NIGHT SWEATS 93 0.0029
296 INJECTION SITE DISCOLOURATION 36 0.0029
297 FOOD CRAVING 15 0.0028
298 EMBEDDED DEVICE 28 0.0028
299 HAND FRACTURE 20 0.0028
300 MICTURITION URGENCY 32 0.0028
301 CEREBROVASCULAR ACCIDENT 473 0.0028
302 DEVICE BREAKAGE 113 0.0028
303 ANXIETY 792 0.0028
304 ANGINA UNSTABLE 18 0.0028
305 HAEMORRHAGE 289 0.0028
306 OBESITY 44 0.0028
307 ABORTION INDUCED 26 0.0028
308 DEVICE ISSUE 247 0.0028
309 ACTIVITIES OF DAILY LIVING IMPAIRED 54 0.0027
310 TRANSIENT ISCHAEMIC ATTACK 92 0.0027
311 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
312 ANKLE FRACTURE 42 0.0027
313 IRON DEFICIENCY ANAEMIA 25 0.0027
314 RESPIRATORY RATE INCREASED 24 0.0027
315 ATELECTASIS 26 0.0027
316 PAIN IN JAW 76 0.0027
317 SLEEP APNOEA SYNDROME 51 0.0027
318 WRONG PRODUCT ADMINISTERED 18 0.0027
319 EXPOSURE VIA SKIN CONTACT 69 0.0027
320 PHOTOPHOBIA 50 0.0027
321 GENERAL PHYSICAL CONDITION ABNORMAL 18 0.0027
322 MASS 37 0.0026
323 NEOPLASM 30 0.0026
324 COLD SWEAT 46 0.0026
325 AFFECT LABILITY 25 0.0026
326 DEVICE DELIVERY SYSTEM ISSUE 71 0.0026
327 CYST 32 0.0026
328 MENTAL DISORDER 112 0.0026
329 SCIATICA 41 0.0026
330 NERVOUSNESS 134 0.0026
331 INFLAMMATORY BOWEL DISEASE 25 0.0026
332 BURSITIS 31 0.0026
333 NOCTURIA 31 0.0026
334 SUICIDAL IDEATION 233 0.0025
335 AFFECTIVE DISORDER 20 0.0025
336 PHARYNGEAL OEDEMA 39 0.0025
337 CHOLECYSTITIS 30 0.0025
338 ODYNOPHAGIA 15 0.0025
339 BLOOD PRESSURE SYSTOLIC INCREASED 49 0.0025
340 HYPOTHYROIDISM 80 0.0025
341 PANIC REACTION 18 0.0025
342 HIATUS HERNIA 32 0.0025
343 FOOD ALLERGY 19 0.0025
344 JOINT DISLOCATION 26 0.0025
345 HYPERTONIA 14 0.0024
346 FORMICATION 17 0.0024
347 METASTASES TO BONE 40 0.0024
348 FOOT DEFORMITY 27 0.0024
349 COMPRESSION FRACTURE 13 0.0024
350 WRIST FRACTURE 29 0.0024
351 PHARYNGITIS 30 0.0024
352 METABOLIC DISORDER 14 0.0024
353 DEPRESSED MOOD 127 0.0024
354 POST PROCEDURAL COMPLICATION 46 0.0024
355 IRRITABILITY 144 0.0024
356 PAROSMIA 18 0.0024
357 PLATELET COUNT INCREASED 31 0.0024
358 ECONOMIC PROBLEM 36 0.0024
359 CARPAL TUNNEL SYNDROME 33 0.0024
360 PHARYNGEAL SWELLING 23 0.0023
361 BLINDNESS UNILATERAL 33 0.0023
362 OCCUPATIONAL EXPOSURE TO PRODUCT 15 0.0023
363 ONYCHOCLASIS 16 0.0023
364 BLOOD URINE PRESENT 44 0.0023
365 HIDRADENITIS 21 0.0023
366 ABDOMINAL DISTENSION 239 0.0023
367 DIABETES MELLITUS 174 0.0023
368 LIP SWELLING 76 0.0023
369 GRAND MAL CONVULSION 21 0.0023
370 DEVICE DEPLOYMENT ISSUE 29 0.0023
371 ARTERIOSCLEROSIS CORONARY ARTERY 15 0.0023
372 BLOOD TRIGLYCERIDES INCREASED 40 0.0023
373 DISTURBANCE IN ATTENTION 122 0.0023
374 URINARY INCONTINENCE 67 0.0023
375 THROAT TIGHTNESS 61 0.0023
376 ABDOMINAL PAIN 524 0.0023
377 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 160 0.0022
378 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 123 0.0022
379 JOINT RANGE OF MOTION DECREASED 30 0.0022
380 ARTERIOSCLEROSIS 21 0.0022
381 FEAR 60 0.0022
382 HUNGER 31 0.0022
383 LIGAMENT SPRAIN 22 0.0022
384 GASTROOESOPHAGEAL REFLUX DISEASE 179 0.0022
385 MULTIPLE INJURIES 14 0.0022
386 PHOTOPSIA 14 0.0022
387 VISUAL FIELD DEFECT 16 0.0022
388 DEVICE DISLOCATION 96 0.0022
389 MANIA 36 0.0022
390 RESPIRATION ABNORMAL 15 0.0022
391 SYSTEMIC LUPUS ERYTHEMATOSUS 77 0.0022
392 CARDIAC FLUTTER 14 0.0022
393 PROCEDURAL PAIN 60 0.0022
394 TOOTH ABSCESS 22 0.0022
395 INTERVERTEBRAL DISC PROTRUSION 47 0.0021
396 PARAESTHESIA ORAL 31 0.0021
397 ANAPHYLACTIC REACTION 118 0.0021
398 ABSCESS 34 0.0021
399 VENTRICULAR EXTRASYSTOLES 22 0.0021
400 PHARMACEUTICAL PRODUCT COMPLAINT 55 0.0021
401 CARDIOMEGALY 26 0.0021
402 MUSCLE DISORDER 17 0.0021
403 ACNE 159 0.0021
404 TOOTH FRACTURE 23 0.0021
405 BONE LOSS 31 0.0021
406 SPINAL COMPRESSION FRACTURE 17 0.0021
407 HYPOAESTHESIA 307 0.0020
408 MATERNAL EXPOSURE BEFORE PREGNANCY 14 0.0020
409 PERIPHERAL COLDNESS 28 0.0020
410 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
411 ANHEDONIA 53 0.0020
412 FACIAL PAIN 18 0.0020
413 UPPER RESPIRATORY TRACT INFECTION 93 0.0020
414 NECK PAIN 112 0.0020
415 INJECTION SITE DISCOMFORT 21 0.0020
416 CONVULSION 114 0.0020
417 NODULE 26 0.0020
418 INCREASED APPETITE 38 0.0020
419 HYPERSOMNIA 57 0.0020
420 JOINT INJURY 42 0.0020
421 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
422 NERVE COMPRESSION 18 0.0019
423 INITIAL INSOMNIA 20 0.0019
424 HEMIPARESIS 33 0.0019
425 FLUID RETENTION 99 0.0019
426 POLLAKIURIA 81 0.0019
427 UPPER-AIRWAY COUGH SYNDROME 16 0.0019
428 PERSONALITY CHANGE 18 0.0019
429 ROAD TRAFFIC ACCIDENT 81 0.0019
430 HEPATIC STEATOSIS 36 0.0019
431 INJECTION SITE INDURATION 25 0.0019
432 EMBOLISM 16 0.0019
433 PULMONARY THROMBOSIS 21 0.0019
434 FLANK PAIN 18 0.0019
435 SINUS DISORDER 38 0.0019
436 PARANOIA 33 0.0019
437 INCORRECT ROUTE OF DRUG ADMINISTRATION 68 0.0019
438 EYE MOVEMENT DISORDER 13 0.0019
439 AGGRESSION 95 0.0019
440 FURUNCLE 15 0.0019
441 BLOOD ALBUMIN DECREASED 15 0.0019
442 AMNESIA 123 0.0019
443 EMOTIONAL DISTRESS 228 0.0019
444 CEREBRAL INFARCTION 46 0.0019
445 OSTEOMYELITIS 34 0.0019
446 BLOOD PRESSURE FLUCTUATION 45 0.0019
447 MUSCULOSKELETAL CHEST PAIN 29 0.0019
448 VITAMIN D DECREASED 16 0.0019
449 OBSESSIVE-COMPULSIVE DISORDER 15 0.0019
450 SINUSITIS 191 0.0019
451 SENSORY LOSS 15 0.0019
452 HYPERCALCAEMIA 23 0.0019
453 CHEST PAIN 345 0.0019
454 ANOREXIA 24 0.0019
455 BASAL CELL CARCINOMA 29 0.0019
456 HEART RATE IRREGULAR 42 0.0019
457 GENERALISED OEDEMA 23 0.0019
458 ARTHRITIS 146 0.0019
459 BRONCHITIS 137 0.0018
460 BONE PAIN 108 0.0018
461 BACK PAIN 428 0.0018
462 TYPE 2 DIABETES MELLITUS 62 0.0018
463 POOR VENOUS ACCESS 19 0.0018
464 SINUS TACHYCARDIA 26 0.0018
465 SYNCOPE 183 0.0018
466 SNEEZING 41 0.0018
467 BEDRIDDEN 24 0.0018
468 COMPLICATION OF DEVICE REMOVAL 33 0.0018
469 ALOPECIA 357 0.0018
470 IMMUNODEFICIENCY 27 0.0018
471 PALPITATIONS 212 0.0018
472 CONCUSSION 14 0.0018
473 CAESAREAN SECTION 21 0.0018
474 HEMIPLEGIA 15 0.0018
475 PALLOR 49 0.0018
476 EAR PAIN 35 0.0018
477 RIB FRACTURE 37 0.0018
478 OBSTRUCTIVE AIRWAYS DISORDER 20 0.0018
479 URTICARIA 301 0.0018
480 HYPERTHYROIDISM 26 0.0018
481 NIGHTMARE 62 0.0018
482 SEXUAL DYSFUNCTION 21 0.0018
483 MUSCLE SPASTICITY 22 0.0018
484 MALNUTRITION 20 0.0018
485 ELECTROCARDIOGRAM ABNORMAL 14 0.0018
486 INSOMNIA 474 0.0018
487 SINUS CONGESTION 24 0.0018
488 OPTIC NEURITIS 16 0.0018
489 RESTLESS LEGS SYNDROME 32 0.0018
490 PHARYNGITIS STREPTOCOCCAL 19 0.0018
491 MUSCLE SPASMS 322 0.0018
492 HYPERTENSION 370 0.0017
493 LOCALISED INFECTION 42 0.0017
494 RHINITIS 14 0.0017
495 KIDNEY INFECTION 34 0.0017
496 HYPOAESTHESIA ORAL 26 0.0017
497 VERTIGO 105 0.0017
498 POOR QUALITY SLEEP 37 0.0017
499 ROTATOR CUFF SYNDROME 22 0.0017
500 BLADDER DISORDER 17 0.0017
501 DIARRHOEA HAEMORRHAGIC 16 0.0017
502 TOOTH DISORDER 38 0.0017
503 METASTASES TO LIVER 30 0.0017
504 MATERNAL EXPOSURE DURING PREGNANCY 152 0.0017
505 INCONTINENCE 18 0.0017
506 HALLUCINATION, AUDITORY 27 0.0017
507 DIVERTICULITIS 47 0.0017
508 SEASONAL ALLERGY 24 0.0017
509 THERAPEUTIC RESPONSE UNEXPECTED 76 0.0017
510 FEELING COLD 47 0.0017
511 PSYCHOMOTOR HYPERACTIVITY 28 0.0017
512 CONGENITAL ANOMALY 13 0.0017
513 IMPAIRED HEALING 55 0.0017
514 MUSCLE RIGIDITY 20 0.0017
515 GASTRITIS 44 0.0017
516 IMPAIRED DRIVING ABILITY 19 0.0017
517 MUSCLE TIGHTNESS 27 0.0017
518 DERMATITIS CONTACT 19 0.0017
519 MYOCARDIAL INFARCTION 290 0.0017
520 MUSCLE ATROPHY 21 0.0017
521 TACHYCARDIA 147 0.0017
522 PAIN 1014 0.0016
523 ADRENAL INSUFFICIENCY 20 0.0016
524 HEART RATE INCREASED 163 0.0016
525 TOOTH LOSS 34 0.0016
526 DEVICE MALFUNCTION 115 0.0016
527 DYSURIA 60 0.0016
528 MENTAL STATUS CHANGES 45 0.0016
529 HEADACHE 1015 0.0016
530 SLEEP DISORDER 114 0.0016
531 DRUG ADMINISTERED AT INAPPROPRIATE SITE 17 0.0016
532 TINNITUS 74 0.0016
533 SWELLING 150 0.0016
534 NAIL DISORDER 14 0.0016
535 SPINAL FRACTURE 32 0.0016
536 RETCHING 34 0.0016
537 BODY HEIGHT DECREASED 17 0.0016
538 CORONARY ARTERY DISEASE 48 0.0016
539 COMPLICATION ASSOCIATED WITH DEVICE 23 0.0016
540 ARRHYTHMIA 75 0.0016
541 FEMUR FRACTURE 49 0.0016
542 MYOCARDIAL ISCHAEMIA 18 0.0016
543 APATHY 23 0.0016
544 GENERALISED TONIC-CLONIC SEIZURE 26 0.0016
545 BODY TEMPERATURE INCREASED 32 0.0016
546 SKIN LESION 43 0.0016
547 QUALITY OF LIFE DECREASED 21 0.0016
548 LETHARGY 90 0.0016
549 CONJUNCTIVITIS 29 0.0016
550 BACK INJURY 17 0.0016
551 NEURALGIA 38 0.0016
552 DEVICE RELATED INFECTION 24 0.0016
553 OEDEMA PERIPHERAL 190 0.0016
554 CARDIOMYOPATHY 23 0.0016
555 METASTASES TO CENTRAL NERVOUS SYSTEM 20 0.0015
556 TENDONITIS 24 0.0015
557 EATING DISORDER 33 0.0015
558 LOCAL SWELLING 27 0.0015
559 DEVICE USE ISSUE 27 0.0015
560 GINGIVAL BLEEDING 21 0.0015
561 HYPERHIDROSIS 198 0.0015
562 PULMONARY HYPERTENSION 32 0.0015
563 COELIAC DISEASE 15 0.0015
564 BODY TEMPERATURE DECREASED 15 0.0015
565 DIZZINESS 749 0.0015
566 FEELING HOT 92 0.0015
567 COAGULOPATHY 25 0.0015
568 FUNGAL INFECTION 50 0.0015
569 CELLULITIS 75 0.0015
570 FRACTURE 28 0.0015
571 PULMONARY MASS 22 0.0015
572 SPUTUM DISCOLOURED 14 0.0015
573 LIMB INJURY 40 0.0015
574 RECALLED PRODUCT ADMINISTERED 14 0.0015
575 PAIN IN EXTREMITY 432 0.0015
576 OESOPHAGITIS 16 0.0015
577 NEPHROLITHIASIS 67 0.0015
578 IMPAIRED QUALITY OF LIFE 21 0.0015
579 DEAFNESS 38 0.0015
580 DEVICE FAILURE 22 0.0014
581 LIVER FUNCTION TEST ABNORMAL 42 0.0014
582 LOSS OF CONSCIOUSNESS 185 0.0014
583 SYNOVITIS 26 0.0014
584 PRESYNCOPE 35 0.0014
585 INJECTION SITE REACTION 99 0.0014
586 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 67 0.0014
587 WHITE BLOOD CELL COUNT INCREASED 55 0.0014
588 BLOOD CALCIUM DECREASED 16 0.0014
589 RENAL PAIN 15 0.0014
590 HAEMATOCRIT DECREASED 28 0.0014
591 EPILEPSY 43 0.0014
592 SEROTONIN SYNDROME 27 0.0014
593 ARTHROPATHY 78 0.0014
594 FEELING ABNORMAL 334 0.0014
595 MUSCULOSKELETAL PAIN 73 0.0014
596 SEIZURE 160 0.0014
597 LYMPHADENOPATHY 49 0.0014
598 CONTUSION 133 0.0014
599 SKIN DISORDER 46 0.0014
600 CHEST DISCOMFORT 141 0.0014
601 SWOLLEN TONGUE 43 0.0014
602 MOUTH ULCERATION 29 0.0014
603 PARAESTHESIA 216 0.0014
604 MOVEMENT DISORDER 44 0.0014
605 TOOTH EXTRACTION 17 0.0014
606 ABDOMINAL PAIN UPPER 281 0.0014
607 ABNORMAL BEHAVIOUR 54 0.0014
608 INJECTION SITE SWELLING 104 0.0014
609 TREATMENT NONCOMPLIANCE 74 0.0014
610 BLOOD TEST ABNORMAL 19 0.0014
611 WEIGHT DECREASED 377 0.0013
612 BLINDNESS 55 0.0013
613 URINARY TRACT INFECTION 230 0.0013
614 DIPLOPIA 35 0.0013
615 HYPERSENSITIVITY 250 0.0013
616 NAUSEA 1065 0.0013
617 THINKING ABNORMAL 25 0.0013
618 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 23 0.0013
619 DIZZINESS POSTURAL 13 0.0013
620 OSTEONECROSIS 44 0.0013
621 PHOTOSENSITIVITY REACTION 22 0.0013
622 STATUS EPILEPTICUS 15 0.0013
623 COLITIS ULCERATIVE 59 0.0013
624 CYSTITIS 42 0.0013
625 ASTHMA 149 0.0013
626 EAR INFECTION 35 0.0013
627 MUSCULOSKELETAL DISORDER 25 0.0013
628 MEDICATION ERROR 73 0.0013
629 SKIN DISCOLOURATION 60 0.0013
630 UPPER LIMB FRACTURE 26 0.0013
631 STAPHYLOCOCCAL INFECTION 43 0.0013
632 VOMITING 611 0.0013
633 BRAIN INJURY 13 0.0013
634 APHONIA 18 0.0013
635 TOOTH INFECTION 17 0.0013
636 EMPHYSEMA 13 0.0013
637 TREMOR 213 0.0013
638 MYALGIA 218 0.0013
639 ASPIRATION 14 0.0013
640 CONDITION AGGRAVATED 386 0.0013
641 BLOOD PRESSURE INCREASED 194 0.0013
642 VISUAL ACUITY REDUCED 42 0.0013
643 VISION BLURRED 173 0.0013
644 SWELLING FACE 82 0.0013
645 RESTLESSNESS 46 0.0013
646 COMPLICATION OF DEVICE INSERTION 25 0.0013
647 ARTHRALGIA 522 0.0013
648 AGITATION 92 0.0013
649 DRUG DISPENSING ERROR 19 0.0012
650 DIABETES MELLITUS INADEQUATE CONTROL 22 0.0012
651 RASH GENERALISED 32 0.0012
652 VIRAL INFECTION 41 0.0012
653 MIDDLE INSOMNIA 23 0.0012
654 BACK DISORDER 20 0.0012
655 DYSARTHRIA 46 0.0012
656 SOMNOLENCE 246 0.0012
657 MUSCULOSKELETAL DISCOMFORT 21 0.0012
658 GASTROENTERITIS VIRAL 22 0.0012
659 ORAL CANDIDIASIS 16 0.0012
660 OSTEONECROSIS OF JAW 30 0.0012
661 METASTASES TO LUNG 14 0.0012
662 PROTEINURIA 23 0.0012
663 NASAL CONGESTION 71 0.0012
664 DRUG ADMINISTRATION ERROR 37 0.0012
665 BALANCE DISORDER 104 0.0012
666 PRURITUS GENERALISED 26 0.0012
667 CHILLS 140 0.0012
668 DERMATITIS ALLERGIC 15 0.0012
669 APHASIA 36 0.0012
670 INJECTION SITE MASS 44 0.0012
671 OROPHARYNGEAL PAIN 110 0.0012
672 PSYCHOTIC DISORDER 35 0.0012
673 INFLAMMATION 61 0.0012
674 HIP FRACTURE 38 0.0012
675 ORAL HERPES 23 0.0012
676 SURGERY 69 0.0012
677 THIRST 21 0.0012
678 OXYGEN SATURATION DECREASED 66 0.0012
679 ABASIA 29 0.0012
680 DYSPEPSIA 115 0.0012
681 ANAPHYLACTIC SHOCK 30 0.0012
682 RASH PAPULAR 26 0.0012
683 GASTRIC ULCER 22 0.0012
684 MEMORY IMPAIRMENT 159 0.0012
685 RED BLOOD CELL COUNT DECREASED 33 0.0012
686 BRAIN FOG 18 0.0011
687 JOINT STIFFNESS 30 0.0011
688 ANAEMIA 218 0.0011
689 MUSCULOSKELETAL STIFFNESS 100 0.0011
690 GENERAL PHYSICAL HEALTH DETERIORATION 132 0.0011
691 HALLUCINATION, VISUAL 24 0.0011
692 SKIN REACTION 16 0.0011
693 COGNITIVE DISORDER 53 0.0011
694 ASTHENIA 426 0.0011
695 FATIGUE 882 0.0011
696 DYSPNOEA 638 0.0011
697 MUSCULAR WEAKNESS 127 0.0011
698 EYE SWELLING 41 0.0011
699 INFUSION RELATED REACTION 73 0.0011
700 IMPAIRED GASTRIC EMPTYING 15 0.0011
701 VISUAL IMPAIRMENT 136 0.0011
702 PREMATURE BABY 33 0.0011
703 DEVICE USE ERROR 38 0.0011
704 LOWER LIMB FRACTURE 21 0.0011
705 INTENTIONAL SELF-INJURY 22 0.0011
706 RASH PRURITIC 59 0.0011
707 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
708 INJECTION SITE PAIN 333 0.0011
709 DRUG INTERACTION 172 0.0011
710 BURNING SENSATION 76 0.0011
711 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 52 0.0011
712 PRODUCT QUALITY ISSUE 147 0.0011
713 HYPOXIA 38 0.0011
714 SICKLE CELL ANAEMIA WITH CRISIS 17 0.0011
715 INFLUENZA 120 0.0011
716 COORDINATION ABNORMAL 15 0.0011
717 LYMPHOCYTE COUNT DECREASED 19 0.0011
718 RECTAL HAEMORRHAGE 46 0.0011
719 ANGIOEDEMA 47 0.0011
720 DISABILITY 21 0.0011
721 PULMONARY CONGESTION 14 0.0011
722 BLOOD PRESSURE DECREASED 70 0.0011
723 NASOPHARYNGITIS 194 0.0011
724 RESPIRATORY ARREST 29 0.0011
725 PARALYSIS 15 0.0010
726 EXPOSURE DURING PREGNANCY 65 0.0010
727 DRUG INTOLERANCE 101 0.0010
728 INCORRECT DOSE ADMINISTERED 238 0.0010
729 MUSCLE TWITCHING 24 0.0010
730 WOUND 29 0.0010
731 DYSPNOEA EXERTIONAL 39 0.0010
732 LYMPHOMA 16 0.0010
733 HAEMOGLOBIN DECREASED 106 0.0010
734 UNEVALUABLE EVENT 78 0.0010
735 DEHYDRATION 137 0.0010
736 SUICIDE ATTEMPT 62 0.0010
737 CORONARY ARTERY OCCLUSION 14 0.0010
738 BACTERIAL INFECTION 19 0.0010
739 CYANOSIS 16 0.0010
740 DEVICE DIFFICULT TO USE 67 0.0010
741 ANGINA PECTORIS 29 0.0010
742 HERPES ZOSTER 58 0.0010
743 CANDIDA INFECTION 17 0.0010
744 DERMATITIS 21 0.0010
745 RASH MACULAR 35 0.0010
746 PRODUCT USE ISSUE 188 0.0010
747 INCORRECT DRUG ADMINISTRATION DURATION 28 0.0010
748 WHEEZING 59 0.0010
749 INFECTION 144 0.0010
750 NERVOUS SYSTEM DISORDER 31 0.0010
751 GAIT DISTURBANCE 190 0.0010
752 HYPOTENSION 199 0.0010
753 DYSPHAGIA 94 0.0010
754 RASH ERYTHEMATOUS 47 0.0010
755 INJURY ASSOCIATED WITH DEVICE 20 0.0010
756 BRONCHOSPASM 14 0.0010
757 PRURITUS 376 0.0010
758 INJECTION SITE RASH 30 0.0010
759 EYE PAIN 55 0.0010
760 SPEECH DISORDER 51 0.0010
761 LIMB DISCOMFORT 30 0.0010
762 DISEASE RECURRENCE 46 0.0010
763 DISCOMFORT 59 0.0010
764 JOINT SWELLING 116 0.0010
765 LACRIMATION INCREASED 29 0.0010
766 LUNG DISORDER 47 0.0010
767 MALAISE 420 0.0010
768 FLUSHING 97 0.0010
769 HYPOKALAEMIA 44 0.0010
770 PERICARDITIS 16 0.0010
771 FLATULENCE 54 0.0010
772 PERICARDIAL EFFUSION 22 0.0010
773 DRY MOUTH 77 0.0009
774 MENTAL IMPAIRMENT 23 0.0009
775 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
776 DRY EYE 47 0.0009
777 HAEMOPTYSIS 26 0.0009
778 CARDIAC DISORDER 87 0.0009
779 HAEMATOMA 24 0.0009
780 CHOKING 18 0.0009
781 FALL 307 0.0009
782 CONFUSIONAL STATE 149 0.0009
783 OEDEMA 50 0.0009
784 DECREASED APPETITE 213 0.0009
785 HEAD INJURY 29 0.0009
786 MULTIPLE FRACTURES 15 0.0009
787 HEART RATE DECREASED 32 0.0009
788 INFLUENZA LIKE ILLNESS 75 0.0009
789 HYPERGLYCAEMIA 33 0.0009
790 HAEMATURIA 31 0.0009
791 HEAD DISCOMFORT 16 0.0009
792 INJECTION SITE ERYTHEMA 112 0.0009
793 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
794 EJECTION FRACTION DECREASED 14 0.0009
795 STEVENS-JOHNSON SYNDROME 20 0.0009
796 COLITIS 34 0.0009
797 ISCHAEMIC STROKE 16 0.0009
798 DEMENTIA 25 0.0009
799 ILLNESS 92 0.0009
800 COUGH 249 0.0009
801 HAEMATOCHEZIA 49 0.0009
802 LEUKOCYTOSIS 16 0.0009
803 GASTROINTESTINAL DISORDER 79 0.0009
804 PLEURAL EFFUSION 53 0.0009
805 RESPIRATORY DISTRESS 24 0.0009
806 THROAT IRRITATION 39 0.0009
807 INJECTION SITE BRUISING 69 0.0009
808 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 45 0.0009
809 CONSTIPATION 188 0.0009
810 DYSKINESIA 35 0.0009
811 DRUG INEFFECTIVE 1132 0.0009
812 CATARACT 51 0.0009
813 NEUROTOXICITY 15 0.0009
814 INJECTION SITE URTICARIA 21 0.0009
815 VENTRICULAR TACHYCARDIA 14 0.0008
816 EPISTAXIS 63 0.0008
817 COMA 40 0.0008
818 PRODUCTIVE COUGH 40 0.0008
819 DYSPHONIA 49 0.0008
820 INJECTION SITE PRURITUS 56 0.0008
821 ACCIDENTAL EXPOSURE TO PRODUCT 86 0.0008
822 HERNIA 16 0.0008
823 OFF LABEL USE 722 0.0008
824 JAUNDICE 22 0.0008
825 MULTIPLE SCLEROSIS 39 0.0008
826 ERYTHEMA 167 0.0008
827 EXPIRED PRODUCT ADMINISTERED 27 0.0008
828 RASH 354 0.0008
829 INTENTIONAL PRODUCT MISUSE 71 0.0008
830 PRODUCT USE IN UNAPPROVED INDICATION 200 0.0008
831 ABDOMINAL DISCOMFORT 135 0.0008
832 BLOOD PRESSURE ABNORMAL 16 0.0008
833 RHINORRHOEA 52 0.0008
834 SEDATION 21 0.0008
835 DEVICE EXPULSION 52 0.0008
836 CARDIAC FAILURE CONGESTIVE 64 0.0008
837 BLOOD CREATININE INCREASED 52 0.0008
838 PANCREATITIS 42 0.0008
839 DIABETIC KETOACIDOSIS 19 0.0008
840 FEEDING DISORDER 16 0.0008
841 CARDIOVASCULAR DISORDER 20 0.0008
842 LABORATORY TEST ABNORMAL 23 0.0008
843 PRESCRIBED OVERDOSE 15 0.0008
844 SKIN ULCER 20 0.0008
845 PYREXIA 267 0.0008
846 PERIPHERAL SWELLING 118 0.0008
847 BLISTER 43 0.0008
848 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 14 0.0008
849 WITHDRAWAL SYNDROME 32 0.0008
850 GLOSSODYNIA 17 0.0008
851 MULTIPLE SCLEROSIS RELAPSE 52 0.0008
852 DISORIENTATION 30 0.0008
853 DYSSTASIA 22 0.0008
854 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
855 PRODUCT PHYSICAL ISSUE 15 0.0007
856 HALLUCINATION 56 0.0007
857 INTESTINAL OBSTRUCTION 28 0.0007
858 DRUG EFFECT DECREASED 40 0.0007
859 FREQUENT BOWEL MOVEMENTS 20 0.0007
860 PSORIATIC ARTHROPATHY 30 0.0007
861 INCORRECT PRODUCT ADMINISTRATION DURATION 16 0.0007
862 OCULAR HYPERAEMIA 35 0.0007
863 FEELING JITTERY 14 0.0007
864 RESPIRATORY TRACT INFECTION 19 0.0007
865 INJECTION SITE WARMTH 15 0.0007
866 GASTRIC DISORDER 25 0.0007
867 DIARRHOEA 468 0.0007
868 ABNORMAL DREAMS 20 0.0007
869 SKIN IRRITATION 33 0.0007
870 INTENTIONAL PRODUCT USE ISSUE 63 0.0007
871 ASPARTATE AMINOTRANSFERASE INCREASED 38 0.0007
872 ORAL PAIN 16 0.0007
873 PRODUCT PRESCRIBING ERROR 17 0.0007
874 PANCREATITIS ACUTE 16 0.0007
875 HEPATITIS 18 0.0007
876 INTENTIONAL DOSE OMISSION 20 0.0007
877 LEUKOPENIA 35 0.0007
878 UNDERDOSE 51 0.0007
879 MOBILITY DECREASED 50 0.0007
880 BLOOD SODIUM DECREASED 13 0.0007
881 INJECTION SITE HAEMORRHAGE 55 0.0007
882 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
883 ALANINE AMINOTRANSFERASE INCREASED 42 0.0007
884 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
885 HYPOGLYCAEMIA 33 0.0007
886 ADVERSE DRUG REACTION 61 0.0007
887 DRUG PRESCRIBING ERROR 13 0.0007
888 GLYCOSYLATED HAEMOGLOBIN INCREASED 17 0.0007
889 HAEMATEMESIS 17 0.0007
890 HYPOPHAGIA 17 0.0007
891 KNEE ARTHROPLASTY 14 0.0007
892 PNEUMONITIS 18 0.0007
893 LUNG NEOPLASM MALIGNANT 27 0.0007
894 PULMONARY OEDEMA 29 0.0006
895 ASCITES 19 0.0006
896 FAECES DISCOLOURED 14 0.0006
897 ACUTE MYOCARDIAL INFARCTION 19 0.0006
898 THERAPEUTIC RESPONSE SHORTENED 21 0.0006
899 LIVER DISORDER 28 0.0006
900 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 21 0.0006
901 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 112 0.0006
902 UNRESPONSIVE TO STIMULI 16 0.0006
903 DYSGEUSIA 46 0.0006
904 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
905 NEUTROPHIL COUNT DECREASED 25 0.0006
906 RENAL FAILURE ACUTE 26 0.0006
907 ECZEMA 32 0.0006
908 SHOCK 14 0.0006
909 EYE DISORDER 20 0.0006
910 RHEUMATOID ARTHRITIS 69 0.0006
911 EYE PRURITUS 20 0.0006
912 PRODUCT DOSE OMISSION ISSUE 175 0.0006
913 CHRONIC KIDNEY DISEASE 45 0.0006
914 PNEUMONIA 189 0.0006
915 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
916 HYPOACUSIS 25 0.0006
917 RENAL DISORDER 27 0.0006
918 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
919 NEOPLASM PROGRESSION 20 0.0006
920 MUCOSAL INFLAMMATION 15 0.0006
921 URINARY RETENTION 19 0.0006
922 DRY SKIN 76 0.0006
923 RESPIRATORY DISORDER 17 0.0006
924 BLOOD POTASSIUM DECREASED 17 0.0006
925 SEPSIS 63 0.0006
926 HEPATIC ENZYME INCREASED 38 0.0006
927 COVID-19 97 0.0006
928 NO ADVERSE EVENT 100 0.0006
929 SEPTIC SHOCK 24 0.0006
930 STOMATITIS 33 0.0005
931 DRUG-INDUCED LIVER INJURY 17 0.0005
932 NEUROPATHY PERIPHERAL 51 0.0005
933 ATRIAL FIBRILLATION 52 0.0005
934 DERMATITIS ATOPIC 28 0.0005
935 DRUG EFFECT INCOMPLETE 19 0.0005
936 C-REACTIVE PROTEIN INCREASED 19 0.0005
937 EYE IRRITATION 30 0.0005
938 PAIN OF SKIN 14 0.0005
939 BLOOD BILIRUBIN INCREASED 14 0.0005
940 GAIT INABILITY 17 0.0005
941 METABOLIC ACIDOSIS 16 0.0005
942 BLOOD GLUCOSE DECREASED 24 0.0005
943 BLOOD GLUCOSE INCREASED 94 0.0005
944 DRUG WITHDRAWAL SYNDROME 43 0.0005
945 HYPERKALAEMIA 17 0.0005
946 PANCYTOPENIA 27 0.0005
947 HEPATIC FAILURE 14 0.0005
948 LOWER RESPIRATORY TRACT INFECTION 21 0.0005
949 RENAL FAILURE 61 0.0005
950 PRODUCT SUBSTITUTION ISSUE 26 0.0005
951 SKIN EXFOLIATION 38 0.0004
952 MALIGNANT NEOPLASM PROGRESSION 46 0.0004
953 DRUG DOSE OMISSION 74 0.0004
954 SKIN BURNING SENSATION 32 0.0004
955 ADVERSE EVENT 41 0.0004
956 NEOPLASM MALIGNANT 29 0.0004
957 CARDIO-RESPIRATORY ARREST 18 0.0004
958 THERAPY NON-RESPONDER 19 0.0004
959 FEBRILE NEUTROPENIA 28 0.0004
960 CEREBRAL HAEMORRHAGE 15 0.0004
961 RENAL IMPAIRMENT 35 0.0004
962 RESPIRATORY FAILURE 30 0.0004
963 THROMBOCYTOPENIA 46 0.0004
964 HYPONATRAEMIA 22 0.0004
965 ILL-DEFINED DISORDER 23 0.0004
966 CARDIAC ARREST 31 0.0004
967 NEUTROPENIA 51 0.0004
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 76 0.0004
969 DELIRIUM 13 0.0004
970 CARDIAC FAILURE 30 0.0004
971 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
972 THERAPEUTIC RESPONSE DECREASED 22 0.0004
973 TOXICITY TO VARIOUS AGENTS 61 0.0004
974 HEPATIC FUNCTION ABNORMAL 13 0.0003
975 PLATELET COUNT DECREASED 37 0.0003
976 BRADYCARDIA 18 0.0003
977 PSORIASIS 44 0.0003
978 OVERDOSE 71 0.0003
979 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 23 0.0003
980 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
981 INTENTIONAL OVERDOSE 20 0.0003
982 INTERSTITIAL LUNG DISEASE 15 0.0003
983 ACUTE KIDNEY INJURY 46 0.0003
984 COMPLETED SUICIDE 25 0.0003
985 DISEASE PROGRESSION 32 0.0003
986 TREATMENT FAILURE 21 0.0003
987 HOSPITALISATION 38 0.0002
988 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
989 PRODUCT DOSE OMISSION 14 0.0002
990 DRUG ABUSE 16 0.0002
991 DRUG DEPENDENCE 27 0.0002
992 DEATH 122 0.0001